vs
Side-by-side financial comparison of BXP, Inc. (BXP) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $872.1M, roughly 1.3× BXP, Inc.). BXP, Inc. runs the higher net margin — 15.3% vs -127.8%, a 143.1% gap on every dollar of revenue. On growth, BXP, Inc. posted the faster year-over-year revenue change (0.8% vs -2.5%). Over the past eight quarters, BXP, Inc.'s revenue compounded faster (1.3% CAGR vs 1.3%).
BXP Inc., operating as Boston Properties, is a leading U.S. real estate investment trust focused on owning, managing and developing high-quality Class A commercial office properties across major U.S. metro markets, serving diverse corporate, tech and professional service tenants.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
BXP vs PRGO — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $872.1M | $1.1B |
| Net Profit | $133.0M | $-1.4B |
| Gross Margin | — | 32.6% |
| Operating Margin | — | -116.0% |
| Net Margin | 15.3% | -127.8% |
| Revenue YoY | 0.8% | -2.5% |
| Net Profit YoY | 53.0% | -3093.9% |
| EPS (diluted) | $1.69 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $872.1M | — | ||
| Q4 25 | $877.1M | $1.1B | ||
| Q3 25 | $871.5M | $1.0B | ||
| Q2 25 | $868.5M | $1.1B | ||
| Q1 25 | $865.2M | $1.0B | ||
| Q4 24 | $858.6M | $1.1B | ||
| Q3 24 | $859.2M | $1.1B | ||
| Q2 24 | $850.5M | $1.1B |
| Q1 26 | $133.0M | — | ||
| Q4 25 | $248.4M | $-1.4B | ||
| Q3 25 | $-121.7M | $7.5M | ||
| Q2 25 | $89.0M | $-8.4M | ||
| Q1 25 | $61.2M | $-6.4M | ||
| Q4 24 | $-228.9M | $-44.4M | ||
| Q3 24 | $83.6M | $-21.0M | ||
| Q2 24 | $79.6M | $-108.4M |
| Q1 26 | — | — | ||
| Q4 25 | 58.8% | 32.6% | ||
| Q3 25 | 59.3% | 36.1% | ||
| Q2 25 | 59.2% | 34.4% | ||
| Q1 25 | 59.2% | 37.6% | ||
| Q4 24 | 59.7% | 33.9% | ||
| Q3 24 | 59.5% | 37.2% | ||
| Q2 24 | 59.8% | 37.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | -116.0% | ||
| Q3 25 | — | 7.0% | ||
| Q2 25 | — | 4.3% | ||
| Q1 25 | — | 4.5% | ||
| Q4 24 | — | 10.0% | ||
| Q3 24 | — | 7.4% | ||
| Q2 24 | — | -2.5% |
| Q1 26 | 15.3% | — | ||
| Q4 25 | 28.3% | -127.8% | ||
| Q3 25 | -14.0% | 0.7% | ||
| Q2 25 | 10.2% | -0.8% | ||
| Q1 25 | 7.1% | -0.6% | ||
| Q4 24 | -26.7% | -3.9% | ||
| Q3 24 | 9.7% | -1.9% | ||
| Q2 24 | 9.4% | -10.2% |
| Q1 26 | $1.69 | — | ||
| Q4 25 | $1.56 | $-10.23 | ||
| Q3 25 | $-0.77 | $0.05 | ||
| Q2 25 | $0.56 | $-0.06 | ||
| Q1 25 | $0.39 | $-0.05 | ||
| Q4 24 | $-1.46 | $-0.32 | ||
| Q3 24 | $0.53 | $-0.15 | ||
| Q2 24 | $0.51 | $-0.79 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $512.8M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $7.7B | $2.9B |
| Total Assets | $25.1B | $8.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $512.8M | — | ||
| Q4 25 | $1.5B | — | ||
| Q3 25 | $861.1M | $432.1M | ||
| Q2 25 | $447.0M | $454.2M | ||
| Q1 25 | $398.1M | $409.9M | ||
| Q4 24 | $1.3B | $558.8M | ||
| Q3 24 | $1.4B | $1.5B | ||
| Q2 24 | $685.4M | $542.8M |
| Q1 26 | $7.7B | — | ||
| Q4 25 | $5.1B | $2.9B | ||
| Q3 25 | $5.0B | $4.4B | ||
| Q2 25 | $5.3B | $4.5B | ||
| Q1 25 | $5.3B | $4.4B | ||
| Q4 24 | $5.4B | $4.3B | ||
| Q3 24 | $5.8B | $4.6B | ||
| Q2 24 | $5.8B | $4.5B |
| Q1 26 | $25.1B | — | ||
| Q4 25 | $26.2B | $8.5B | ||
| Q3 25 | $26.0B | $10.1B | ||
| Q2 25 | $25.6B | $10.1B | ||
| Q1 25 | $25.4B | $9.8B | ||
| Q4 24 | $26.1B | $9.6B | ||
| Q3 24 | $26.4B | $11.2B | ||
| Q2 24 | $25.5B | $10.4B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $175.4M |
| Free Cash FlowOCF − Capex | — | $148.6M |
| FCF MarginFCF / Revenue | — | 13.4% |
| Capex IntensityCapex / Revenue | 1.5% | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $407.8M | $175.4M | ||
| Q3 25 | $274.2M | $51.7M | ||
| Q2 25 | $353.1M | $75.9M | ||
| Q1 25 | $210.0M | $-64.5M | ||
| Q4 24 | $383.7M | $312.6M | ||
| Q3 24 | $286.1M | $42.2M | ||
| Q2 24 | $367.1M | $9.5M |
| Q1 26 | — | — | ||
| Q4 25 | $362.7M | $148.6M | ||
| Q3 25 | $231.6M | $29.8M | ||
| Q2 25 | $281.5M | $56.7M | ||
| Q1 25 | $152.6M | $-90.0M | ||
| Q4 24 | $312.5M | $274.9M | ||
| Q3 24 | $234.5M | $15.1M | ||
| Q2 24 | $332.4M | $-18.9M |
| Q1 26 | — | — | ||
| Q4 25 | 41.4% | 13.4% | ||
| Q3 25 | 26.6% | 2.9% | ||
| Q2 25 | 32.4% | 5.4% | ||
| Q1 25 | 17.6% | -8.6% | ||
| Q4 24 | 36.4% | 24.2% | ||
| Q3 24 | 27.3% | 1.4% | ||
| Q2 24 | 39.1% | -1.8% |
| Q1 26 | 1.5% | — | ||
| Q4 25 | 5.1% | 2.4% | ||
| Q3 25 | 4.9% | 2.1% | ||
| Q2 25 | 8.2% | 1.8% | ||
| Q1 25 | 6.6% | 2.4% | ||
| Q4 24 | 8.3% | 3.3% | ||
| Q3 24 | 6.0% | 2.5% | ||
| Q2 24 | 4.1% | 2.7% |
| Q1 26 | — | — | ||
| Q4 25 | 1.64× | — | ||
| Q3 25 | — | 6.89× | ||
| Q2 25 | 3.97× | — | ||
| Q1 25 | 3.43× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.42× | — | ||
| Q2 24 | 4.61× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BXP
| Lease | $818.2M | 94% |
| Parking and other | $30.8M | 4% |
| Development and management services | $9.2M | 1% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
